Your browser is no longer supported. Please, upgrade your browser.
Settings
AEZS Aeterna Zentaris Inc. daily Stock Chart
AEZS [NASD]
Aeterna Zentaris Inc.
Index- P/E16.87 EPS (ttm)0.25 Insider Own0.60% Shs Outstand16.46M Perf Week-7.61%
Market Cap69.96M Forward P/E- EPS next Y-0.60 Insider Trans0.00% Shs Float16.38M Perf Month0.95%
Income4.20M PEG- EPS next Q0.04 Inst Own21.40% Short Float5.85% Perf Quarter11.84%
Sales26.90M P/S2.60 EPS this Y121.90% Inst Trans6.66% Short Ratio3.43 Perf Half Y175.97%
Book/sh0.12 P/B35.42 EPS next Y-126.70% ROA13.80% Target Price5.50 Perf Year187.16%
Cash/sh0.88 P/C4.82 EPS next 5Y- ROE55.10% 52W Range1.29 - 5.57 Perf YTD44.56%
Dividend- P/FCF- EPS past 5Y14.90% ROI157.40% 52W High-23.70% Beta1.28
Dividend %- Quick Ratio2.90 Sales past 5Y34.20% Gross Margin92.20% 52W Low229.46% ATR0.29
Employees56 Current Ratio2.90 Sales Q/Q600.00% Oper. Margin31.80% RSI (14)40.89 Volatility6.45% 6.94%
OptionableYes Debt/Eq0.00 EPS Q/Q-960.50% Profit Margin15.60% Rel Volume0.50 Prev Close4.31
ShortableYes LT Debt/Eq0.00 EarningsMar 26 AMC Payout0.00% Avg Volume279.13K Price4.25
Recom- SMA20-9.62% SMA50-0.47% SMA20049.79% Volume139,195 Change-1.39%
Jul-19-17Reiterated Maxim Group Buy $2 → $4
May-10-17Reiterated H.C. Wainwright Buy $7.50 → $3
May-01-17Reiterated Maxim Group Buy $11 → $2
Jan-17-17Reiterated Maxim Group Buy $7 → $10
Dec-02-15Reiterated H.C. Wainwright Buy $11 → $12
Nov-24-15Reiterated H.C. Wainwright Buy $0.11 → $11
Nov-23-15Reiterated Maxim Group Buy $200 → $11
Apr-14-15Upgrade H.C. Wainwright Neutral → Buy $1.25
Nov-06-14Downgrade H.C. Wainwright Buy → Neutral
Jul-17-14Initiated H.C. Wainwright Buy $3
Jan-03-13Upgrade MLV & Co Hold → Buy $5.50
Oct-09-12Initiated Maxim Group Buy $9
Apr-02-12Downgrade MLV & Co Buy → Hold
Jun-07-11Initiated Oppenheimer Outperform $5.50
Apr-27-11Reiterated Canaccord Genuity Speculative Buy $2.75 → $4
Nov-29-10Initiated MLV Capital Buy $5.50
Feb-05-09Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-03-08Reiterated Canaccord Adams Buy $3.20 → $2.65
Apr-14-08Reiterated Canaccord Adams Buy $4.50 → $3.20
Oct-03-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Mar-26-19 07:50PM  Aeterna Zentaris: 4Q Earnings Snapshot Associated Press
05:22PM  Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire
Mar-19-19 08:00AM  Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire +5.50%
Mar-18-19 11:18AM  Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade Zacks
Mar-13-19 07:27AM  The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga +8.40%
Mar-12-19 04:32PM  Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire
Mar-04-19 08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks -5.50%
Feb-27-19 09:57AM  The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris Zacks
Feb-26-19 08:55AM  4 Drug Stocks to Buy Despite Price Hearing Woes Zacks
Feb-14-19 10:45AM  The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks
Feb-13-19 08:36AM  5 Tiny Biotech Stocks With Superb Growth Potential Zacks
Jan-29-19 09:30AM  Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
08:48AM  Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options Zacks
Jan-16-19 09:03AM  Aeterna Zentaris Receives European Marketing Clearance for Macimorelin GlobeNewswire -10.00%
Jan-09-19 09:50AM  Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan Zacks
Jan-07-19 09:30AM  Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year? Zacks
Dec-24-18 05:50PM  Aeterna Zentaris (AEZS) Stock Moves -1.16%: What You Should Know Zacks
Dec-21-18 05:04PM  Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore GlobeNewswire -5.82%
Dec-20-18 09:30AM  Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-17-18 05:50PM  Aeterna Zentaris (AEZS) Gains As Market Dips: What You Should Know Zacks
Dec-07-18 05:45PM  Aeterna Zentaris (AEZS) Stock Moves -0.54%: What You Should Know Zacks
Dec-04-18 12:51PM  Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? Zacks -5.43%
Nov-30-18 05:41AM  Can The Uptrend Continue for Aeterna Zentaris (AEZS)? Zacks +7.64%
Nov-19-18 09:00AM  4 Healthcare Stocks Taking a New Approach to Growth Trends ACCESSWIRE
08:00AM  Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency GlobeNewswire
Nov-16-18 10:50AM  4 Healthcare Stocks Turning Toward Tech For New Growth ACCESSWIRE +14.17%
07:40AM  Consolidated Research: 2018 Summary Expectations for Western Gas Partners, LP, HCA Healthcare, DHI Group, AEterna Zentaris, Tsakos Energy Navigation, and Acme United Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-06-18 07:54PM  Aeterna Zentaris: 3Q Earnings Snapshot Associated Press
06:14PM  Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
08:00AM  Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC GlobeNewswire
Nov-01-18 08:20AM  Aeterna Zentaris Soars on Macrilen(TM) Out Licensing Deal, Analysts Review and Target ACCESSWIRE
08:00AM  Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen in United States and Canada GlobeNewswire
07:50AM  Todays Research Reports on Stocks to Watch: Aeterna Zentaris and AbbVie ACCESSWIRE
Oct-31-18 04:05PM  Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018 GlobeNewswire +67.69%
12:00PM  3 Healthcare Stocks Leading New Industry Trends ACCESSWIRE
Sep-25-18 08:00AM  Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer GlobeNewswire
Aug-10-18 07:27AM  What is Behind Aeterna Zentaris Incs (TSE:AEZS) Superior ROE? Simply Wall St.
06:30AM  Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE
Aug-09-18 06:57PM  Aeterna Zentaris: 2Q Earnings Snapshot Associated Press
04:19PM  Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
Aug-02-18 04:05PM  Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018 GlobeNewswire
May-31-18 04:15PM  Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH GlobeNewswire -9.54%
May-29-18 08:44AM  Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session Zacks +12.96%
May-25-18 08:44AM  VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher Zacks +6.41%
May-24-18 08:46AM  MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session Zacks
May-16-18 08:45AM  Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher Zacks
May-14-18 02:10PM  5 Top Profitable Stocks With Terrific Growth InvestorPlace
09:47AM  Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors Zacks
May-11-18 09:24AM  5 Top Profitable Stocks With Terrific Growth in the Offing Zacks +6.87%
May-08-18 04:15PM  Aeterna Zentaris Announces Results of Annual and Special Shareholders Meeting GlobeNewswire -5.79%
07:55AM  Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure Benzinga
May-07-18 06:41PM  Aeterna Zentaris: 1Q Earnings Snapshot Associated Press
04:15PM  Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results GlobeNewswire
May-01-18 05:05PM  Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018 GlobeNewswire
Apr-19-18 07:20AM  Wired News Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinsons Disease Dementia ACCESSWIRE
Apr-09-18 08:00AM  Aeterna Zentaris Files Management Information Circular GlobeNewswire
Mar-28-18 07:37AM  Aeterna Zentaris reports 4Q loss Associated Press -7.12%
07:00AM  Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results GlobeNewswire
06:30AM  Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE
Mar-24-18 12:02PM  March Best Growth Stocks Simply Wall St.
Mar-21-18 04:05PM  Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018 GlobeNewswire
Mar-05-18 04:05PM  Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer GlobeNewswire -8.94%
07:45AM  Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit GlobeNewswire
Feb-18-18 11:02AM  Top TSX Growth Stocks To Buy Simply Wall St.
Jan-29-18 01:40PM  5 Great Breakout Stocks Offering Superlative Returns InvestorPlace
Jan-19-18 08:20AM  Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service Zacks
Jan-18-18 09:32AM  5 Great Breakout Stocks Offering Superlative Returns Zacks -5.39%
08:15AM  Heres Whats Moving Novartis And Aeterna Zentaris Right Now Market Exclusive
Jan-17-18 10:03AM  AEterna Zentaris Inc. (USA) (AEZS) Stock Fires Up to the Roof; Heres Why SmarterAnalyst +16.43%
07:00AM  Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN (macimorelin) from Aeterna Zentaris GlobeNewswire
07:00AM  Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen (macimorelin) in the U.S. and Canada GlobeNewswire
Dec-22-17 04:15PM  Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore GlobeNewswire -9.26%
Dec-21-17 10:55AM  Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold Yahoo Finance +34.33%
10:41AM  Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold Yahoo Finance Video
09:12AM  U.S. stocks remain on track to open near records after GDP data MarketWatch
08:55AM  Stocks push slightly higher, President Trump prepares to sign tax bill into law Yahoo Finance
08:23AM  Aeterna Zentaris' stock soars toward 8-month high after Macrilen granted marketing approval MarketWatch
08:22AM  IIROC Trade Resumption - Aeterna Zentaris Inc. Newsfile
07:20AM  Yahoo Finance Live: Market Movers - Dec 21st, 2017 Yahoo Finance Video
07:12AM  Heres How AbbVie (NYSE:ABBV) and Aeterna Zentaris Inc. (NASDAQ:AEZS) Just Picked Up Early Christmas Present Market Exclusive
Dec-20-17 07:00PM  AEterna Zentaris Inc. (USA) (AEZS) Investors Celebrate FDA Approval; Shares Skyrocket SmarterAnalyst
05:39PM  Canada's Aeterna gets FDA approval for growth hormone deficiency test Reuters
05:00PM  Aeterna Zentaris Announces FDA Approval of Macrilen (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency GlobeNewswire
04:01PM  IIROC Trade Halt - Aeterna Zentaris Inc. Newsfile
Dec-08-17 09:59AM  Ahead of Big Catalyst, AEterna Zentaris Inc. (AEZS) Announced Departure of Interim Chief Financial Officer SmarterAnalyst
08:00AM  Aeterna Zentaris Announces Departure of Interim Chief Financial Officer GlobeNewswire
Nov-30-17 08:34AM  Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates Benzinga
Nov-28-17 08:00AM  Today's Research Reports on Trending Tickers: Aeterna Zentaris and Intercept Pharmaceuticals ACCESSWIRE
Nov-27-17 05:21PM  AEterna Zentaris Inc.s (USA) (AEZS) Growth Hormone Drug Accepted for EU Review SmarterAnalyst
04:41PM  Aeterna Zentaris Marketing Authorization Application for Macrilen (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency GlobeNewswire
Nov-13-17 09:39AM  Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube
Nov-09-17 05:01AM  Aeterna Zentaris reports 3Q loss Associated Press
Nov-08-17 05:38PM  Company Update: AEterna Zentaris Inc. (AEZS) Announces 3Q:17 Highlights and Financial Results SmarterAnalyst
05:05PM  Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results Business Wire
Nov-02-17 05:47PM  Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017 Business Wire
Sep-25-17 04:30PM  Aeterna Zentaris Announces Appointment of Interim Chief Financial Officer Business Wire
Sep-01-17 04:30PM  Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer Business Wire
Aug-24-17 11:17AM  Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-14-17 08:10AM  Today's Research Reports on Stocks to Watch: EnteroMedics and Aterna Zentaris ACCESSWIRE
Aug-11-17 07:00AM  Investor Network: Aeterna Zentaris Inc. to Host Earnings Call ACCESSWIRE +17.92%
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology, endocrinology, and women's health. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. It also has a collaboration agreement with Sinopharm A-Think Pharmaceuticals Co., Ltd. for the development, manufacture, and commercialization of Zoptrex, which has completed Phase III clinical study for women with advanced, recurrent, or metastatic endometrial cancer in the People's Republic of China. Aeterna Zentaris Inc. was founded in 1991 and is headquartered in Summerville, South Carolina.